MicroRNAs and prostate cancer

Valeria Coppola, Ruggero De Maria Marchiano, Désirée Bonci

Risultato della ricerca: Contributo in rivistaArticolo in rivista

114 Citazioni (Scopus)


Despite much progress in prostate cancer management, new diagnostic, prognostic and therapeutic tools are needed to predict disease severity, choose among the available treatments and establish more effective therapies for advanced prostate cancer. In the last few years, compelling evidence has documented the role of microRNAs as new broad-spectrum oncogenes or tumour suppressor genes, thus their use as diagnostic, prognostic and therapeutic biomolecules is envisaged. This review extensively and critically summarizes the current knowledge about microRNAderegulation in prostate cancer disease, underlining present limits and future perspectives. © 2010 Society for Endocrinology.
Lingua originaleEnglish
pagine (da-a)1-17
Numero di pagine17
RivistaEndocrine-Related Cancer
Stato di pubblicazionePubblicato - 2010


  • Adenocarcinoma
  • Androgens
  • Cancer Research
  • Cell Transformation, Neoplastic
  • Disease Progression
  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Gene Expression Profiling
  • Gene Expression Regulation, Neoplastic
  • Genes, Tumor Suppressor
  • Humans
  • Male
  • MicroRNAs
  • Neoplasm Invasiveness
  • Neoplasm Proteins
  • Neoplasms, Hormone-Dependent
  • Oncology
  • Prognosis
  • Prostatic Neoplasms
  • Proto-Oncogene Proteins c-myc
  • RNA, Neoplasm


Entra nei temi di ricerca di 'MicroRNAs and prostate cancer'. Insieme formano una fingerprint unica.

Cita questo